Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Canada, United States (Insulin glargine, 300 U/ml, Insulin glargine, 100 U/ml, Insulin detemir)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine, 300 U/ml
  • +3 more
  • Birmingham, Alabama
  • +426 more
Aug 28, 2019

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +105 more
Sep 3, 2018

Diabetes, Type 2 Trial in Worldwide (GSK523338)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Tucson, Arizona
  • +84 more
Apr 2, 2018

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, Metformin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Tucson, Arizona
  • +41 more
Mar 19, 2018

Diabetes, Type 2 Trial in Worldwide (Placebo, DEN 2.5 mg, DEN 7.5 mg)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Placebo
  • +5 more
  • Long Beach, California
  • +108 more
Mar 19, 2018

Diabetes, Type 2 Trial in Canada (rosiglitazone/metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Calgary, Alberta, Canada
  • +90 more
Mar 19, 2018

Diabetes, Type 2 Trial in Worldwide (rosiglitazone maleate/metformin HCl)

Completed
  • Diabetes Mellitus, Type 2
  • rosiglitazone maleate/metformin hydrochloride
  • Anniston, Alabama
  • +101 more
Mar 19, 2018

Diabetes, Type 2 Trial in Worldwide (rosiglitazone/metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +93 more
Mar 19, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +301 more
Feb 16, 2018

Diabetes, Type 2 Trial in Worldwide (GSK189075, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Mesa, Arizona
  • +156 more
Sep 26, 2017

Type 2 Diabetes Mellitus inUsual Clinical Practice in Canada

Completed
  • Diabetes Mellitus, Type 2
  • No Intervention
  • Calgary, Alberta, Canada
  • +22 more
Oct 27, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, , liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Anaheim, California
  • +131 more
Aug 25, 2017

Diabetes, Type 2 Trial in Worldwide (pioglitazone, rosiglitazone, )

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Long Beach, California
  • +330 more
Mar 21, 2017

Diabetes, Type 2 Trial in Worldwide (Pioglitazone, GW677954)

Completed
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +142 more
Mar 21, 2017

Diabetes, Type 2 Trial in Worldwide (Placebo, PF-04937319 10 mg, PF-04937319 50 mg)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Placebo
  • +4 more
  • Roseville, California
  • +52 more
Dec 6, 2016

Diabetes, Type 2 Trial in Worldwide (Avandamet 6 mg/1500 mg (ttd), Avandamet 4 mg/1000 mg (ttd), Avandamet 2 mg/500 mg (ttd))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Avandamet 6 mg/1500 mg (ttd)
  • +7 more
  • Tuscaloosa, Alabama
  • +115 more
Oct 11, 2016

Diabetes, Type 2 Trial in Worldwide (Canagliflozin, 100 mg, Canagliflozin, 300 mg, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Canagliflozin, 100 mg
  • +2 more
  • Montgomery, Alabama
  • +56 more
Oct 28, 2016

Diabetes, Type 2 Trial in Brampton, Toronto (Naturopathic Care, Usual (Conventional) Care)

Unknown status
  • Diabetes Mellitus, Type 2
  • Naturopathic Care
  • Usual (Conventional) Care
  • Brampton, Ontario, Canada
  • +1 more
Jul 21, 2016

Diabetes, Type 2 Trial in Worldwide (BI 10773 low dose, Placebo BI 10773 high dose, BI 10773 high dose)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • BI 10773 low dose
  • +3 more
  • Birmingham, Alabama
  • +614 more
Apr 7, 2016

Diabetes, Type 2, Hypertension Trial in Worldwide (Placebo, BI 10773)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Hypertension
  • Placebo
  • BI 10773
  • Huntsville, Alabama
  • +119 more
Jan 22, 2016

Diabetes, Type 2 Trial in Worldwide (Placebo, empagliflozin (low dose qd), Empagliflozin (high dose qd))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Placebo
  • +4 more
  • Florence, Alabama
  • +138 more
Jun 26, 2015

Diabetes, Type 2 Trial in Worldwide (high dose FDC, BI 10773 high dose, high dose FDC )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • high dose FDC
  • +10 more
  • Birmingham, Alabama
  • +210 more
Apr 1, 2015

Diabetes, Type 2 Trial in Worldwide (Sitagliptin 100 mg, Canagliflozin 300 mg, Metformin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Sitagliptin 100 mg
  • +3 more
  • Mobile, Alabama
  • +183 more
Jan 5, 2015

Diabetes, Type 2 Trial in Worldwide (Canagliflozin 50 mg, Placebo, Canagliflozin 150 mg)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Canagliflozin 50 mg
  • +3 more
  • Little Rock, Arkansas
  • +63 more
Sep 5, 2014